ForSight Robotics, founded in 2020, is at the forefront of revolutionizing ophthalmic surgery with its flagship product, ORYOM. This innovative platform leverages advanced computer vision, AI-based machine learning, and microsurgical robotics to enhance the precision and accessibility of eye surgeries, particularly for cataracts and widespread eye diseases.
Committed to democratizing quality surgical eye care, ForSight Robotics aims to extend the reach of expert eye surgery to patients worldwide, restoring vision and hope for millions. The company operates in the Health Care, Medical Devices, and Robotics industries.
In its recent funding round, ForSight Robotics raised a substantial $55.00M in a Series A investment on 18 July 2022. Notable investors include Eclipse Ventures, Mithril Capital, Adani Group, Provenio Capital, Precision Capital Advisors, The Ljungstrom Family Office, and Reiya ventures. This investment underscores confidence in the company's mission to transform global healthcare through technological innovation.
Moon Surgical
